Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative study of mupirocin versus topical fusidic acid in eradication of nasal carriage of Staphylococcus aureus in patients with chronic renal failure on hemodialysis by indwelling catheter. [Estudio comparativo de mupirocina versus acido fusidico tipico en la erradicacion de portadores nasales de Staphylococcus aureus en pacientes con insuficiencia renal cronica en hemodialisis por cateter permanente]

Trial Profile

Comparative study of mupirocin versus topical fusidic acid in eradication of nasal carriage of Staphylococcus aureus in patients with chronic renal failure on hemodialysis by indwelling catheter. [Estudio comparativo de mupirocina versus acido fusidico tipico en la erradicacion de portadores nasales de Staphylococcus aureus en pacientes con insuficiencia renal cronica en hemodialisis por cateter permanente]

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fusidic acid (Primary) ; Mupirocin (Primary)
  • Indications Catheter infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2011 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top